{
    "organizations": [],
    "uuid": "0ebc8d653d500c46a5868f37afd6438c68e1cd6f",
    "author": "",
    "url": "https://www.reuters.com/article/brief-european-commission-approves-brist/brief-european-commission-approves-bristol-myers-squibbs-yervoy-idUSFWN1PH0MS",
    "ord_in_thread": 0,
    "title": "BRIEF-European Commission Approves Bristol-Myers Squibb's Yervoy",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 15 PM / Updated 6 minutes ago BRIEF-European Commission Approves Bristol-Myers Squibb's Yervoy Reuters Staff 1 Min Read \nJan 22 (Reuters) - Bristol-Myers Squibb Co: \n* EUROPEAN COMMISSION APPROVES BRISTOL-MYERS SQUIBBâ€™S YERVOY (IPILIMUMAB) FOR TREATMENT OF PEDIATRIC PATIENTS 12 YEARS AND OLDER WITH UNRESECTABLE OR METASTATIC MELANOMA \n* BRISTOL-MYERS SAYS EC EXPANDED INDICATION OF YERVOY TO INCLUDE TREATMENT OF ADVANCED MELANOMA IN PEDIATRIC PATIENTS 12 YRS OF AGE & OLDER Source text for Eikon: Further company coverage:",
    "published": "2018-01-22T14:13:00.000+02:00",
    "crawled": "2018-01-22T15:01:54.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "commission",
        "approves",
        "squibb",
        "yervoy",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "squibb",
        "co",
        "european",
        "commission",
        "approves",
        "squibb",
        "yervoy",
        "ipilimumab",
        "treatment",
        "pediatric",
        "patient",
        "year",
        "older",
        "unresectable",
        "metastatic",
        "melanoma",
        "say",
        "ec",
        "expanded",
        "indication",
        "yervoy",
        "include",
        "treatment",
        "advanced",
        "melanoma",
        "pediatric",
        "patient",
        "yr",
        "age",
        "older",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}